In the past two years, since Hardman & Co first started to target the IC sector, we have heard many managers of ICs and boards talk of the growth of the retail investor on their registers. Many have approached Hardman & Co for help in addressing this market, since we have a unique strength in this field relative to other providers.
05 Feb 2021
THE MONTHLY February 2021
Advanced Oncotherapy Plc (AVO:LON), 39.0 | Arbuthnot Banking Group PLC (ARBB:LON), 1,160 | BBGI Sicav (BBGI:LON), 172 | City of London Investment Group PLC (CLIG:LON), 537 | Diurnal Group plc (DNL:LON), 71.5 | Filta Group Holdings PLC (FLTA:LON), 146 | ICG Enterprise Trust (ICGT:LON), 1,057 | Oakley Capital Investments (OCI:LON), 311 | Palace Capital plc (PCA:LON), 234 | Pantheon International (PIN:LON), 2,732 | Primary Health Properties PLC (PHP:LON), 149 | Real Estate Credit Investments (RECI:LON), 141 | Shield Therapeutics Plc (STX:LON), 47.0 | Tissue Regenix Group plc (TRX:LON), 0.6 | Volta Finance (VTA:LON), 602 | Yew Grove REIT plc (YEW:LON), 95.0
-
-
-
Hardman & Co Research Team
-
37 pages
-


Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
THE MONTHLY February 2021
Advanced Oncotherapy Plc (AVO:LON), 39.0 | Arbuthnot Banking Group PLC (ARBB:LON), 1,160 | BBGI Sicav (BBGI:LON), 172 | City of London Investment Group PLC (CLIG:LON), 537 | Diurnal Group plc (DNL:LON), 71.5 | Filta Group Holdings PLC (FLTA:LON), 146 | ICG Enterprise Trust (ICGT:LON), 1,057 | Oakley Capital Investments (OCI:LON), 311 | Palace Capital plc (PCA:LON), 234 | Pantheon International (PIN:LON), 2,732 | Primary Health Properties PLC (PHP:LON), 149 | Real Estate Credit Investments (RECI:LON), 141 | Shield Therapeutics Plc (STX:LON), 47.0 | Tissue Regenix Group plc (TRX:LON), 0.6 | Volta Finance (VTA:LON), 602 | Yew Grove REIT plc (YEW:LON), 95.0
- Published:
05 Feb 2021 -
Author:
Hardman & Co Research Team -
Pages:
37 -
In the past two years, since Hardman & Co first started to target the IC sector, we have heard many managers of ICs and boards talk of the growth of the retail investor on their registers. Many have approached Hardman & Co for help in addressing this market, since we have a unique strength in this field relative to other providers.